Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
64,670,984
-
Number of holders
-
158
-
Total 13F shares, excl. options
-
54,269,227
-
Shares change
-
-4,056,421
-
Total reported value, excl. options
-
$333,225,539
-
Value change
-
-$49,044,182
-
Put/Call ratio
-
308%
-
Number of buys
-
78
-
Number of sells
-
-90
-
Price
-
$6.14
Significant Holders of Evolus, Inc. - Common Stock, par value $0.00001 per share (EOLS) as of Q3 2025
207 filings reported holding EOLS - Evolus, Inc. - Common Stock, par value $0.00001 per share as of Q3 2025.
Evolus, Inc. - Common Stock, par value $0.00001 per share (EOLS) has 158 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54,269,227 shares
of 64,670,984 outstanding shares and own 84% of the company stock.
Largest 10 shareholders include Nantahala Capital Management, LLC (5,726,857 shares), TANG CAPITAL MANAGEMENT LLC (5,488,299 shares), BlackRock, Inc. (4,476,691 shares), Caligan Partners LP (4,138,943 shares), VANGUARD GROUP INC (3,428,943 shares), Frazier Life Sciences Management, L.P. (2,630,665 shares), MILLENNIUM MANAGEMENT LLC (1,859,003 shares), Stonepine Capital Management, LLC (1,536,391 shares), STATE STREET CORP (1,515,217 shares), and Eversept Partners, LP (1,475,109 shares).
This table shows the top 158 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.